Neos Therapeutics, Inc
NEOS
NEOS was delisted on the 19th of March, 2021.
49 hedge funds and large institutions have $14.6M invested in Neos Therapeutics, Inc in 2020 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 7 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 11
4.47% less ownership
Funds ownership: 43.58% → 39.11% (-4.5%)
9% less funds holding
Funds holding: 54 → 49 (-5)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
91% less capital inflows, than outflows
Capital inflows: $317K | Capital outflows: $3.44M
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $8K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$47.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$47.1K |
| 3 |
Goldman Sachs
New York
|
+$44.9K |
| 4 |
Millennium Management
New York
|
+$31.9K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$29K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.4M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$874K |
| 3 |
Boston Partners
Boston,
Massachusetts
|
-$347K |
| 4 |
Stonepine Capital Management
Bend,
Oregon
|
-$232K |
| 5 |
JP Morgan Chase
New York
|
-$144K |
NEOS Hedge Fund Activity: Q1 2020 in Review
49 of the 4,549 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q1 2020, worth a combined $14.6M — down 55% from $32.7M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of NEOS and 5 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 11 added.
The largest buyer was Renaissance Technologies, adding an estimated $47.2K. The largest seller was Sphera Funds Management, cutting an estimated $1.4M.
- 49 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q1 2020, down from 54 in Q4 2019.
- Funds reported $14.6M of Neos Therapeutics, Inc stock for Q1 2020, down 55% quarter-over-quarter.
- 5 funds opened new Neos Therapeutics, Inc positions in Q1 2020 and 7 closed out, a net change of -2 holders.
- The largest Neos Therapeutics, Inc buyer in Q1 2020 was Renaissance Technologies, an estimated $47.2K added.
- The largest Neos Therapeutics, Inc seller in Q1 2020 was Sphera Funds Management, an estimated $1.4M sold.
Based on aggregated 13F filings for Q1 2020.